The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases
Open accessAbstract
CRISPR RNA-guided nucleases (RGNs) are widely used genome-editing reagents, but methods to delineate their genome-wide, off-target cleavage activities have been lacking. Here we describe an approach for global detection of DNA double-stranded breaks (DSBs) introduced by RGNs and potentially other nucleases. This method, called genome-wide, unbiased identification of DSBs enabled by sequencing (GUIDE-seq), relies on capture of double-stranded oligodeoxynucleotides into DSBs. Application of GUIDE-seq to 13 RGNs in two human cell lines revealed wide variability in RGN off-target activities and unappreciated characteristics of off-target sequences. The majority of identified sites were not detected by existing computational methods or chromatin immunoprecipitation sequencing (ChIP-seq). GUIDE-seq also identified RGN-independent genomic breakpoint 'hotspots'. Finally, GUIDE-seq revealed that truncated guide RNAs exhibit substantially reduced RGN-induced, off-target DSBs. Our experiments define the most rigorous framework for genome-wide identification of RGN off-target effects to date and provide a method for evaluating the safety of these nucleases before clinical use.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“A primary limitation of GUIDE-seq is relevant to the low delivery efficiency of dsODNs into cells, which results in detection of only 30%–50% of all the DSBs (Tsai et al., 2015; Pan et al., 2022).”
From Off-target effects in CRISPR/Cas9 gene editing (2023) · cites this paper as Tsai et al., 2015
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Off-target profiling of AsCas12a-crRNA+11 genome editing in HEK293/3272-26A>G cells18,42 showed very high specificity, as demonstrated by exclusive editing of the 3272-26A>G CFTR locus, while non-specific cleavages in the second allele, or any other genomic loci, could not be detected (Fig. 2c and Supplementary Fig. 4c).”
From Allele specific repair of splicing mutations in cystic fibrosis through AsCas12a genome editing (2019) · cites this paper as [42]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“While cleavage at sites with perfect complementarity to the protospacer domain of the gRNA typically occurs with highest efficiency, cleavage at sites having one to several bases of mismatch with the gRNA can occur. These undesired cleavage events are called “off-target effects” (OTEs)10, and their existence should be minimized for therapeutic applications of genome editing technologies.”
From A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cells (2018) · cites this paper as [10]
The cited source says what the claim attributes to it.
In the citing paper
“The GUIDE-seq procedure10 can be used to empirically identify real off-target sites in cells.”
From A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cells (2018) · cites this paper as [10]
The cited source says what the claim attributes to it.
In the citing paper
“GUIDE-seq can detect off-target sites with indel frequencies as low as 0.03% (Tsai et al., 2015).”
From Off-target effects in CRISPR/Cas9 gene editing (2023) · cites this paper as Tsai et al., 2015
The cited source says what the claim attributes to it.
In the citing paper
“GUIDE-seq is more sensitive than the IDLV method because dsODNs integrate more efficiently and precisely into DSBs, while the integration events of IDLV is low in number and can distribute as far as 500bp away from the actual DSB sites (Tsai et al., 2015; Cromer et al., 2023).”
From Off-target effects in CRISPR/Cas9 gene editing (2023) · cites this paper as Tsai et al., 2015
The cited source says what the claim attributes to it.
In the citing paper
“However, other publications observed a much lower validation rate (Cencic et al., 2014; Duan et al., 2014; Tsai et al., 2015).”
From Off-target effects in CRISPR/Cas9 gene editing (2023) · cites this paper as Tsai et al., 2015
The cited source says what the claim attributes to it.
In the citing paper
“These studies indicated that Cas9 could associate with genomic loci without exerting its nuclease function, deposing a major caveat in Cas9 ChIP-Seq-based off-target detection assay.”
From Off-target effects in CRISPR/Cas9 gene editing (2023) · cites this paper as Tsai et al., 2015
The cited source says what the claim attributes to it.
In the citing paper
“Interestingly, compared to cell-based methods such as GUIDE-seq (see next section) (Tsai et al., 2015), Extru-seq exhibited much lower false negative rate (2.3% versus 29%) (Kwon et al., 2023).”
From Off-target effects in CRISPR/Cas9 gene editing (2023) · cites this paper as Tsai et al., 2015
In the citing paper
“Using the standard Guide-seq protocol, we detected only the Fah target site and one off-target site (defined as Guide-seq off-target site 1, or GOT1) (Supplementary Data Set 1).”
From Adenine base editing in an adult mouse model of tyrosinaemia (2019) · cites this paper as [23]
In the citing paper
“However, silicon methods can only identify part of the off-target cleavage.48”
From CRISPR-Cas9: a new and promising player in gene therapy (2015) · cites this paper as [48]
In the citing paper
“The major barrier of clinical use of CRISPR/Cas9 is its off-target effects [81,82,83].”
From Viral Delivery Systems for CRISPR (2019) · cites this paper as [81]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fast and accurate short read alignment with Burrows-Wheeler transform
Li, H., & Durbin, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp324 · Cited by 58,607
A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012) · Science · doi:10.1126/science.1225829 · Cited by 17,116
Fast and accurate long-read alignment with Burrows-Wheeler transform.
Li, H., & Durbin, R. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btp698 · Cited by 12,063
Genome engineering using the CRISPR-Cas9 system
Ran, F. A., Hsu, P. D., Wright, J., Agarwala, V., Scott, D. A., & Zhang, F. (2013) · Nature Protocols · doi:10.1038/nprot.2013.143 · Cited by 11,133
Development and Applications of CRISPR-Cas9 for Genome Engineering
Hsu, P. D., Lander, E. S., & Zhang, F. (2014) · Cell · doi:10.1016/j.cell.2014.05.010 · Cited by 5,762
DNA targeting specificity of RNA-guided Cas9 nucleases
Hsu, P. D., Scott, D. A., Weinstein, J. A., Ran, F. A., Konermann, S., Agarwala, V., Li, Y., Fine, E. J., Wu, X., Shalem, O., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2647 · Cited by 4,741
Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity
Ran, F. A., Hsu, P. D., Lin, C.-Y., Gootenberg, J. S., Konermann, S., Trevino, A. E., Scott, D. A., Inoue, A., Matoba, S., Zhang, Y., et al. (2013) · Cell · doi:10.1016/j.cell.2013.08.021 · Cited by 3,299
High-Frequency off-Target Mutagenesis Induced by CRISPR-Cas Nucleases in Human Cells
Fu, Y., Foden, J. A., Khayter, C., Maeder, M. L., Reyon, D., Joung, J. K., & Sander, J. D. (2013) · Nature Biotechnology · doi:10.1038/nbt.2623 · Cited by 3,292
Self-citationCRISPR-Cas systems for editing, regulating and targeting genomes
Sander, J. D., & Joung, J. K. (2014) · Nature Biotechnology · doi:10.1038/nbt.2842 · Cited by 3,153
Self-citationRNA-guided editing of bacterial genomes using CRISPR-Cas systems
Jiang, W., Bikard, D., Cox, D., Zhang, F., & Marraffini, L. A. (2013) · Nature Biotechnology · doi:10.1038/nbt.2508 · Cited by 2,429
Flagged first, then by citations
Cited by
Sorted by citations
Items 401–500 of 1,009
Comprehensive assessment of miniature CRISPR-Cas12f nucleases for gene disruption
Xin, C., Yin, J., Yuan, S., Ou, L., Liu, M., Zhang, W., & Hu, J. (2022) · Nature Communications · doi:10.1038/s41467-022-33346-1 · Cited by 95
CRISPR/Cas9 Landscape: Current State and Future Perspectives
Tyumentsev, A. I., Tyumentsev, A. I., & Акимкин, В. Г. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242216077 · Cited by 98
Achieving Plant CRISPR Targeting that Limits Off‐Target Effects
Wolt, J. D., Wang, K., Sashital, D. G., & Lawrence‐Dill, C. J. (2016) · The Plant Genome · doi:10.3835/plantgenome2016.05.0047 · Cited by 101
CRISPR-Cas9 Circular Permutants as Programmable Scaffolds for Genome Modification
Oakes, B. L., Fellmann, C., Rishi, H. S., Taylor, K. L., Ren, S. M., Nadler, D. C., Yokoo, R., Arkin, A. P., Doudna, J. A., & Savage, D. F. (2019) · Cell · doi:10.1016/j.cell.2018.11.052 · Cited by 94
Li, C., Georgakopoulou, A., Mishra, A., Gil, S., Hawkins, R. D., Yannaki, E., & Lieber, A. (2021) · Blood Advances · doi:10.1182/bloodadvances.2020003702 · Cited by 96
Biased and unbiased methods for the detection of off-target cleavage by CRISPR/Cas9: An overview
Martin, F., Sánchez-Hernández, S., Gutiérrez-Guerrero, A., Pinedo-Gomez, J., & Benabdellah, K. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17091507 · Cited by 92
“Keith Joung’s team recently developed a revolutionary new platform called GUIDE-seq (genome-wide unbiased identification of DSBs evaluated by sequencing) [30].”
BackgroundMethodInfluentialNext-generation DNA damage sequencing
Mingard, C., Wu, J., McKeague, M., & Sturla, S. J. (2020) · Chemical Society Reviews · doi:10.1039/d0cs00647e · Cited by 92
Off‐target effects of engineered nucleases
Yee, J. (2016) · FEBS Journal · doi:10.1111/febs.13760 · Cited by 95
In vivo genome and base editing of a human PCSK9 knock-in hypercholesterolemic mouse model
Carreras, A., Pane, L. S., Nitsch, R., Madeyski-Bengtson, K., Porritt, M. J., Akçakaya, P., Taheri‐Ghahfarokhi, A., Ericson, E., Bjursell, M., Pérez-Alcázar, M., et al. (2019) · BMC Biology · doi:10.1186/s12915-018-0624-2 · Cited by 93
Discovery of Diverse CRISPR-Cas Systems and Expansion of the Genome Engineering Toolbox
Koonin, E. V., Gootenberg, J. S., & Abudayyeh, O. O. (2023) · Biochemistry · doi:10.1021/acs.biochem.3c00159 · Cited by 95
Kemaladewi, D. U., Maino, E., Hyatt, E., Hou, H., Ding, M., Place, K. M., Zhu, X., Bassi, P. S., Baghestani, Z., Deshwar, A. G., et al. (2017) · Nature Medicine · doi:10.1038/nm.4367 · Cited by 96
CRISPR off-target detection with DISCOVER-seq
Wienert, B., Wyman, S. K., Yeh, C. D., Conklin, B. R., & Corn, J. E. (2020) · Nature Protocols · doi:10.1038/s41596-020-0309-5 · Cited by 98
Improvements in Gene Editing Technology Boost Its Applications in Livestock
Périssé, I. V., Fan, Z., Singina, G. N., White, K. L., & Polejaeva, I. A. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2020.614688 · Cited by 88
Genome editing in cardiovascular diseases
Strong, A., & Musunuru, K. (2016) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2016.139 · Cited by 91
Puget, N., Miller, K. M., & Legube, G. (2019) · DNA repair · doi:10.1016/j.dnarep.2019.102661 · Cited by 90
CRISPR-enhanced human adipocyte browning as cell therapy for metabolic disease
Tsagkaraki, E., Nicoloro, S. M. C., DeSouza, T., Solivan-Rivera, J., Desai, A., Lifshitz, L. M., Shen, Y., Kelly, M., Guilherme, A., Henriques, F. D. S., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-27190-y · Cited by 97
Versatility of chemically synthesized guide RNAs for CRISPR-Cas9 genome editing
Kelley, M. L., Strezoska, Ž., He, K., Vermeulen, A., & Smith, A. V. B. (2016) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2016.06.011 · Cited by 89
Salk, J. J., & Kennedy, S. R. (2019) · Environmental and Molecular Mutagenesis · doi:10.1002/em.22342 · Cited by 92
Cas9, Cpf1 and C2c1/2/3―What's next?
Nakade, S., Yamamoto, T., & Sakuma, T. (2017) · Bioengineered · doi:10.1080/21655979.2017.1282018 · Cited by 92
Spisák, S., Lawrenson, K., Fu, Y., Csabai, I., Cottman, R. T., Seo, J.-H., Haiman, C. A., Han, Y., Lenci, R., Li, Q., et al. (2015) · Nature Medicine · doi:10.1038/nm.3975 · Cited by 88
Self-citationCRISPR library designer (CLD): software for multispecies design of single guide RNA libraries
Heigwer, F., Zhan, T., Breinig, M., Winter, J., Brügemann, D., Leible, S., & Boutros, M. (2016) · Genome biology · doi:10.1186/s13059-016-0915-2 · Cited by 92
Contracting CAG/CTG repeats using the CRISPR-Cas9 nickase
Cinesi, C., Aeschbach, L., Yang, B., & Dion, V. (2016) · Nature Communications · doi:10.1038/ncomms13272 · Cited by 95
Defining genome-wide CRISPR–Cas genome-editing nuclease activity with GUIDE-seq
Malinin, N. L., Lee, G., Lazzarotto, C. R., Li, Y., Zheng, Z., Nguyen, N. T., Liebers, M. R., Topkar, V. V., Iafrate, A. J., Le, L. P., et al. (2021) · Nature Protocols · doi:10.1038/s41596-021-00626-x · Cited by 91
Self-citationYan, X., Pan, Q., Xin, H., Chen, Y., & Yuan, P. (2021) · Science Advances · doi:10.1126/sciadv.abj0624 · Cited by 88
Frequency and mechanisms of LINE-1 retrotransposon insertions at CRISPR/Cas9 sites
Tao, J., Wang, Q., Mendez‐Dorantes, C., Burns, K. H., & Chiarle, R. (2022) · Nature Communications · doi:10.1038/s41467-022-31322-3 · Cited by 91
Deep learning improves the ability of sgRNA off-target propensity prediction
Liu, Q., Cheng, X., Liu, G., Li, B., & Liu, X. (2020) · BMC Bioinformatics · doi:10.1186/s12859-020-3395-z · Cited by 88
McAuley, G. E., Yiu, G., Chang, P. C., Newby, G. A., Campo-Fernández, B., Fitz‐Gibbon, S. T., Xiaomeng, W., Kang, S.-H. L., Garibay, A., Butler, J., et al. (2023) · Cell · doi:10.1016/j.cell.2023.02.027 · Cited by 90
Integrated design, execution, and analysis of arrayed and pooled CRISPR genome-editing experiments
Canver, M. C., Haeussler, M., Bauer, D. E., Orkin, S. H., Sanjana, N. E., Shalem, O., Yuan, G., Zhang, F., Concordet, J., & Pinello, L. (2018) · Nature Protocols · doi:10.1038/nprot.2018.005 · Cited by 91
Wang, Y., Liu, K. I., Sutrisnoh, N.-A. B., Srinivasan, H., Zhang, J., Li, J., Zhang, F., Richard, J. L. C., Xing, H., Shanmugam, R., et al. (2018) · Genome biology · doi:10.1186/s13059-018-1445-x · Cited by 91
Allele specific repair of splicing mutations in cystic fibrosis through AsCas12a genome editing
Maule, G., Casini, A., Montagna, C., Ramalho, A. S., De Boeck, K., Debyser, Z., Carlon, M. S., Petris, G., & Cereseto, A. (2019) · Nature Communications · doi:10.1038/s41467-019-11454-9 · Cited by 86
Precise genome-wide base editing by the CRISPR Nickase system in yeast
Satomura, A., Nishioka, R., Mori, H., Sato, K., Kuroda, K., & Ueda, M. (2017) · Scientific Reports · doi:10.1038/s41598-017-02013-7 · Cited by 89
Development and Application of Base Editors
Yang, B., Yang, L. C., & Chen, J. (2019) · The CRISPR Journal · doi:10.1089/crispr.2019.0001 · Cited by 87
Pavani, G., Fabiano, A., Laurent, M., Amor, F., Cantelli, E., Chalumeau, A., Maule, G., Tachtsidi, A., Concordet, J., Cereseto, A., et al. (2021) · Blood Advances · doi:10.1182/bloodadvances.2020001996 · Cited by 88
CRISPR/Cas9 for plant genome editing: accomplishments, problems and prospects
Paul, J. W., & Qi, Y. (2016) · Plant Cell Reports · doi:10.1007/s00299-016-1985-z · Cited by 90
Kim, J. (2016) · Nature Protocols · doi:10.1038/nprot.2016.104 · Cited by 89
Agapito-Tenfen, S. Z., Okoli, A. S., Bernstein, M. J., Wikmark, O.-G., & Myhr, A. I. (2018) · Frontiers in Plant Science · doi:10.3389/fpls.2018.01874 · Cited by 89
Wang, L., Yang, Y., Breton, C. A., White, J., Zhang, J., Che, Y., Saveliev, A., McMenamin, D., He, Z., Latshaw, C., et al. (2019) · Blood · doi:10.1182/blood.2019000790 · Cited by 85
Koç, E., & Karayiğit, B. (2021) · Journal of soil science and plant nutrition · doi:10.1007/s42729-021-00663-1 · Cited by 86
Chemical Modifications of CRISPR RNAs to Improve Gene-Editing Activity and Specificity
Rozners, E. (2022) · Journal of the American Chemical Society · doi:10.1021/jacs.2c02633 · Cited by 89
Genomes in Focus: Development and Applications of CRISPR‐Cas9 Imaging Technologies
Knight, S. C., Tjian, R., & Doudna, J. A. (2017) · Angewandte Chemie International Edition · doi:10.1002/anie.201709201 · Cited by 86
Genome editing in crop improvement: Present scenario and future prospects
Miglani, G. S. (2017) · Journal of Crop Improvement · doi:10.1080/15427528.2017.1333192 · Cited by 86
Teixeira, M., Py, B. F., Bosc, C., Laubreton, D., Moutin, M., Marvel, J., Flamant, F., & Markossian, S. (2018) · Scientific Reports · doi:10.1038/s41598-017-18826-5 · Cited by 93
In vivo blunt-end cloning through CRISPR/Cas9-facilitated non-homologous end-joining
Geisinger, J. M., Turan, S., Hernandez, S., Spector, L. P., & Calos, M. P. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1542 · Cited by 86
CRISPR/Cas9 Technology and Its Utility for Crop Improvement
Liu, H., Chen, W., Li, Y., Sun, L., Chai, Y., Chen, H., Nie, H., & Huang, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810442 · Cited by 85
CRISPR-Cas: A robust technology for enhancing consumer-preferred commercial traits in crops
Verma, V., Kumar, A., Partap, M., Thakur, M., & Bhargava, B. (2023) · Frontiers in Plant Science · doi:10.3389/fpls.2023.1122940 · Cited by 84
Gene Editing With CRISPR/Cas9 RNA-Directed Nuclease
Doetschman, T., & Georgieva, T. G. (2017) · Circulation Research · doi:10.1161/circresaha.116.309727 · Cited by 91
Lopes, R., & Prasad, M. K. (2024) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1339189 · Cited by 82
Anti-CRISPRdb: a comprehensive online resource for anti-CRISPR proteins
Dong, C., Hao, G., Hua, H., Liu, S., Labena, A. A., Chai, G., Huang, J. H., Rao, N., & Guo, F. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx835 · Cited by 82
iGUIDE: an improved pipeline for analyzing CRISPR cleavage specificity
Nobles, C. L., Reddy, S. G., Salas-McKee, J., Liu, X., June, C. H., Melenhorst, J. J., Suhoski, M. M., Zhao, Y., & Bushman, F. D. (2019) · Genome biology · doi:10.1186/s13059-019-1625-3 · Cited by 82
Genome editing in sea urchin embryos by using a CRISPR/Cas9 system
Lin, C.-Y., & Su, Y. (2015) · Developmental Biology · doi:10.1016/j.ydbio.2015.11.018 · Cited by 82
Germ line genome editing in clinics: the approaches, objectives and global society
Ishii, T. (2015) · Briefings in Functional Genomics · doi:10.1093/bfgp/elv053 · Cited by 84
Chen, P., Zhou, J., Wan, Y., Liu, H., Li, Y., Liu, Z., Wang, H., Lei, J., Zhao, K., Zhang, Y., et al. (2020) · Genome biology · doi:10.1186/s13059-020-01989-2 · Cited by 86
Internal checkpoint regulates T cell neoantigen reactivity and susceptibility to PD1 blockade
Palmer, D. C., Webber, B. R., Patel, Y. K., Johnson, M. J., Kariya, C. M., Lahr, W. S., Parkhurst, M. R., Gartner, J. J., Prickett, T. D., Lowery, F. J., et al. (2022) · Med · doi:10.1016/j.medj.2022.07.008 · Cited by 82
Antoniou, P., Hardouin, G., Martinucci, P., Frati, G., Félix, T., Chalumeau, A., Fontana, L., Martin, J., Masson, C., Brusson, M., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-34493-1 · Cited by 85
Genome-wide CRISPR off-target prediction and optimization using RNA-DNA interaction fingerprints
Chen, Q., Chuai, G., Zhang, H., Tang, J., Duan, L., Guan, H., Li, W., Li, W., Wen, J., Zuo, E., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-42695-4 · Cited by 89
Germline genome-editing research and its socioethical implications
Ishii, T. (2015) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2015.05.006 · Cited by 86
New traits in crops produced by genome editing techniques based on deletions
van de Wiel, C. C. M., Schaart, J. G., Lotz, L. A. P., & Smulders, M. J. M. (2017) · Plant Biotechnology Reports · doi:10.1007/s11816-017-0425-z · Cited by 80
CRISPR system in filamentous fungi: Current achievements and future directions
Deng, H., Gao, R., Liao, X., & Cai, Y. (2017) · Gene · doi:10.1016/j.gene.2017.06.019 · Cited by 81
CRISPR GUARD protects off-target sites from Cas9 nuclease activity using short guide RNAs
Coelho, M. A., Braekeleer, E. D., Firth, M. A., Biśta, M., Łukasiak, S., Cuomo, M. E., & Taylor, B. (2020) · Nature Communications · doi:10.1038/s41467-020-17952-5 · Cited by 84
dCas9-based gene editing for cleavage-free genomic knock-in of long sequences
Wang, C., Qu, Y., Cheng, J. K. W., Hughes, N. W., Zhang, Q., Wang, M., & Cong, L. (2022) · Nature Cell Biology · doi:10.1038/s41556-021-00836-1 · Cited by 82
Athanasopoulou, K., Michalopoulou, V.-I., Scorilas, A., & Adamopoulos, P. G. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb47060470 · Cited by 85
Iyombe-Engembe, J.-P., Ouellet, D. L., Barbeau, X., Rousseau, J., Chapdelaine, P., Lagüe, P., & Tremblay, J. P. (2016) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2015.58 · Cited by 80
Non-homologous DNA increases gene disruption efficiency by altering DNA repair outcomes
Richardson, C. D., Ray, G. J., Bray, N., & Corn, J. E. (2016) · Nature Communications · doi:10.1038/ncomms12463 · Cited by 85
Raveux, A., Vandormael‐Pournin, S., & Cohen‐Tannoudji, M. (2017) · Scientific Reports · doi:10.1038/srep42661 · Cited by 81
Optimization of CRISPR/Cas9 genome editing for loss-of-function in the early chick embryo
Gandhi, S., Piacentino, M. L., Vieceli, F. M., & Bronner-Fraser, M. E. (2017) · Developmental Biology · doi:10.1016/j.ydbio.2017.08.036 · Cited by 79
Multiplexed CRISPR-Cas9-Based Genome Editing of Rhodosporidium toruloides
Otoupal, P. B., Ito, M., Arkin, A. P., Magnuson, J. K., Gladden, J. M., & Skerker, J. M. (2019) · mSphere · doi:10.1128/msphere.00099-19 · Cited by 79
Multiplex base- and prime-editing with drive-and-process CRISPR arrays
Yuan, Q., & Gao, X. (2022) · Nature Communications · doi:10.1038/s41467-022-30514-1 · Cited by 85
Genome-wide profiling of prime editor off-target sites in vitro and in vivo using PE-tag
Liang, S., Liu, P., Ponnienselvan, K., Suresh, S., Chen, Z., Kramme, C. C., Chatterjee, P., Zhu, L. J., Sontheimer, E. J., Xue, W., et al. (2023) · Nature Methods · doi:10.1038/s41592-023-01859-2 · Cited by 86
Chen, W., Ma, J., Wu, Z., Wang, Z., Zhang, H., Fu, W., Pan, D., Jin, S. K., & Ji, Q. (2023) · Molecular Cell · doi:10.1016/j.molcel.2023.06.014 · Cited by 80
CRISPR Variants for Gene Editing in Plants: Biosafety Risks and Future Directions
Movahedi, A., Dargiri, S. A., Li, H., Zhuge, Q., & Sun, W. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242216241 · Cited by 83
Targeted nonviral delivery of genome editors in vivo
Tsuchida, C. A., Wasko, K. M., Hamilton, J. R., & Doudna, J. A. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2307796121 · Cited by 85
Imaging Specific Genomic DNA in Living Cells
Chen, B., Guan, J., & Huang, B. (2016) · Annual Review of Biophysics · doi:10.1146/annurev-biophys-062215-010830 · Cited by 77
Xu, X., Duan, D., & Chen, S. (2017) · Scientific Reports · doi:10.1038/s41598-017-00180-1 · Cited by 79
Suzuki, S., Crane, A. M., Anirudhan, V., Barillá, C., Matthias, N., Randell, S. H., Rab, A., Sorscher, E. J., Kerschner, J. L., Yin, S., et al. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2020.04.021 · Cited by 78
Open-source guideseq software for analysis of GUIDE-seq data
Tsai, S. Q., Topkar, V. V., Joung, J. K., & Aryee, M. J. (2016) · Nature Biotechnology · doi:10.1038/nbt.3534 · Cited by 78
Self-citationRe-visiting the Protamine-2 locus: deletion, but not haploinsufficiency, renders male mice infertile
Schneider, S., Balbach, M., Jikeli, J. F., Fietz, D., Nettersheim, D., Jostes, S., Schmidt, R., Kressin, M., Bergmann, M., Wachten, D., et al. (2016) · Scientific Reports · doi:10.1038/srep36764 · Cited by 78
Programmable DNA looping using engineered bivalent dCas9 complexes
Hao, N., Shearwin, K. E., & Dodd, I. B. (2017) · Nature Communications · doi:10.1038/s41467-017-01873-x · Cited by 80
Simultaneous reprogramming and gene editing of human fibroblasts
Howden, S. E., Thomson, J. A., & Little, M. H. (2018) · Nature Protocols · doi:10.1038/nprot.2018.007 · Cited by 78
Highly efficient and precise base editing in discarded human tripronuclear embryos
Li, G., Liu, Y., Zeng, Y., Li, J., Wang, L., Yang, G., Chen, D., Shang, X., Chen, J., Huang, X., et al. (2017) · Protein & Cell · doi:10.1007/s13238-017-0458-7 · Cited by 77
Dubreuil, M. M., Morgens, D. W., Okumoto, K., Honsho, M., Contrepois, K., Lee‐McMullen, B., Traber, G. M., Sood, R. S., Dixon, S. J., Snyder, M. P., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.01.013 · Cited by 80
Custom CRISPR–Cas9 PAM variants via scalable engineering and machine learning
Silverstein, R. A., Kim, N., Kroell, A.-S. H., Walton, R. T., Delano, J., Butcher, R. M., Pačesa, M., Smith, B., Christie, K. A., Ha, L. L., et al. (2025) · Nature · doi:10.1038/s41586-025-09021-y · Cited by 87
Self-citationtCRISPRi: tunable and reversible, one-step control of gene expression
Li, X., Jun, Y., Erickstad, M. J., Brown, S. D., Parks, A. R., Court, D. L., & Jun, S. (2016) · Scientific Reports · doi:10.1038/srep39076 · Cited by 77
Applications of CRISPR Genome Engineering in Cell Biology
Wang, F., & Qi, L. S. (2016) · Trends in Cell Biology · doi:10.1016/j.tcb.2016.08.004 · Cited by 79
5′-Modifications improve potency and efficacy of DNA donors for precision genome editing
Ghanta, K. S., Chen, Z., Mir, A., Dokshin, G. A., Krishnamurthy, P. M., Yoon, Y., Gallant, J., Xu, P., Zhang, X.-O., Ozturk, A. R., et al. (2021) · eLife · doi:10.7554/elife.72216 · Cited by 76
Modeling CRISPR-Cas13d on-target and off-target effects using machine learning approaches
Cheng, X., Li, Z., Shan, R., Li, Z., Wang, S., Zhao, W., Zhang, H., Chao, L., Peng, J., Teng, F., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-36316-3 · Cited by 83
Unlocking the Therapeutic Applicability of LNP-mRNA: Chemistry, Formulation, and Clinical Strategies
Huang, X., Ma, Y., Ma, G., & Xia, Y. (2024) · Research · doi:10.34133/research.0370 · Cited by 76
CRISPR-Cas9 genome engineering: Treating inherited retinal degeneration
Burnight, E. R., Giacalone, J. C., Cooke, J. A., Thompson, J. R., Bohrer, L. R., Chirco, K. R., Drack, A. V., Fingert, J. H., Worthington, K. S., Wiley, L. A., et al. (2018) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2018.03.003 · Cited by 79
Dreyer, A.-K., Hoffmann, D., Lachmann, N., Ackermann, M., Steinemann, D., Timm, B., Siler, U., Reichenbach, J., Grez, M., Moritz, T., et al. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.07.057 · Cited by 75
Reverse Transcriptase: From Transcriptomics to Genome Editing
Martín-Alonso, S., Frutos-Beltrán, E., & Menéndez‐Arias, L. (2020) · Trends in biotechnology · doi:10.1016/j.tibtech.2020.06.008 · Cited by 76
Atkins, A., Chung, C.-H., Allen, A. G., Dampier, W., Gurrola, T. E., Sariyer, I. K., Nonnemacher, M. R., & Wigdahl, B. L. (2021) · Frontiers in Genome Editing · doi:10.3389/fgeed.2021.673022 · Cited by 78
Targeted Gene Manipulation in Plants Using the CRISPR/Cas Technology
Zhang, D., Li, Z., & Li, J.-F. (2016) · Journal of Genetics and Genomics · doi:10.1016/j.jgg.2016.03.001 · Cited by 67
Versatile and robust genome editing with Streptococcus thermophilus CRISPR1-Cas9Preprint
Agudelo, D., Carter, S., Velimirovic, M., Duringer, A., Rivest, J.-F., Levesque, S., Loehr, J., Mouchiroud, M., Cyr, D., Waters, P. J., et al. (2020) · Genome Research · doi:10.1101/gr.255414.119 · Cited by 75
Non-viral chimeric antigen receptor (CAR) T cells going viral
Balke‐Want, H., Keerthi, V., Cadiñanos-Garai, A., Fowler, C., Gkitsas-Long, N., Brown, A. K., Tunuguntla, R. H., Abou‐El‐Enein, M., & Feldman, S. A. (2023) · Immuno-Oncology Technology · doi:10.1016/j.iotech.2023.100375 · Cited by 75
Recent application of CRISPR-Cas12 and OMEGA system for genome editing
Badon, I. W., Oh, Y., Kim, H., & Lee, S. H. (2023) · Molecular Therapy · doi:10.1016/j.ymthe.2023.11.013 · Cited by 75
SUV39H1 Ablation Enhances Long-term CAR T Function in Solid Tumors
López-Cobo, S., Fuentealba, J. R., Gueguen, P., Bonté, P.-E., Tsalkitzi, K., Chacón, I., Glauzy, S., Bohineust, A., Biquand, A., Silva, L., et al. (2024) · Cancer Discovery · doi:10.1158/2159-8290.cd-22-1350 · Cited by 72
Wen, W., Quan, Z.-J., Li, S.-A., Yang, Z.-X., Fu, Y.-W., Zhang, F., Li, G., Zhao, M., Yin, M., Xu, J., et al. (2021) · Genome biology · doi:10.1186/s13059-021-02462-4 · Cited by 77
Távora, F. T. P. K., Diniz, F. D. A. D. S., Rêgo-Machado, C. M., Freitas, N. C., Arraes, F. B. M., de Andrade, E. C., Furtado, L. L., Osiro, K. O., de Sousa, N. L., Cardoso, T. B., et al. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.913728 · Cited by 73
Schimmel, J., Muñoz-Subirana, N., Kool, H., van Schendel, R., van der Vlies, S., Kamp, J. A., de Vrij, F. M. S., Kushner, S. A., Smith, G. C. M., Boulton, S. J., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112019 · Cited by 72
The clinical applications of genome editing in HIV
Wang, C. X., & Cannon, P. M. (2016) · Blood · doi:10.1182/blood-2016-01-678144 · Cited by 74
Bisaria, N., Jarmoskaite, I., & Herschlag, D. (2017) · Cell Systems · doi:10.1016/j.cels.2016.12.010 · Cited by 74
Metadata
- Authors
- Tsai, S. Q., Zheng, Z., Nguyen, N. T., Liebers, M., Topkar, V. V., Thapar, V., Wyvekens, N., Khayter, C., Iafrate, A. J., Le, L. P., Aryee, M. J., & Joung, J. K.
- Affiliations
- Harvard University (US)
- Massachusetts General Hospital (US)
- Corresponding author
- Tsai, Shengdar Q
- Joung, J Keith
- ORCID
- Venue
- Nature Biotechnology
- Published
- 2014-12-16
- Volume
- 33
- Issue
- 2
- Pages
- 187-197
- ISSN
- 0733-222X (ISSN-L)
- 1087-0156
- 1546-1696
- PMC
- PMC4320685
- OpenAlex
- W2003797386
- Cited by
- 2,268
- References
- 39
- Citations by year
- 2026: 189 · 2025: 211 · 2024: 196 · 2023: 191 · 2022: 208 · 2021: 211 · 2020: 231 · 2019: 186 · 2018: 187 · 2017: 177 · 2016: 172 · 2015: 105 · 2014: 1
- FWCI
- 62.14
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Nature Biotechnology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- Funders
- National Institute of General Medical Sciences (DP1GM105378, R01GM088040, F32GM105189)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR063070)
- National Center for Chronic Disease Prevention and Health Promotion (DP1 GM105378)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Keywords
- GUIDE-seq, CRISPR-Cas nucleases, off-target cleavage, DNA double-strand breaks, genome-wide characterization, genome editing safety
- MeSH terms
- RNA, Guide, CRISPR-Cas Systems, Cell Line, Humans, Oligodeoxyribonucleotides, Genome, Human, RNA Editing, DNA Breaks, Double-Stranded, High-Throughput Nucleotide Sequencing, CRISPR-Cas Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
